Technology
Health
Biotechnology

HTG Molecular

$2.46
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.07 (2.93%) Today
+$0.07 (2.93%) Today

Why Robinhood?

You can buy or sell HTG Molecular and other stocks, options, ETFs, and crypto commission-free!

About

HTG Molecular Diagnostics, Inc. engages in the provision of molecular technology solutions that facilitates molecular profiling. Its customers include biopharmaceutical companies, academic research centers, and molecular testing laboratories. Read More The company was founded by Bruce E. Seligmann in October 1997 and is headquartered in Tucson, AZ.

Employees
107
Headquarters
Tucson, Arizona
Founded
1997
Market Cap
68.32M
Price-Earnings Ratio
—
Dividend Yield
0.00
Average Volume
533.86K
High Today
$2.50
Low Today
$2.40
Open Price
$2.40
Volume
65.75K
52 Week High
$5.83
52 Week Low
$2.03

Collections

Technology
Health
Biotechnology
Biopharmaceutical
Pharmaceutical
2015 IPO
US
North America

News

Seeking AlphaMar 12

HTG Molecular Diagnostics, Inc. (HTGM) CEO TJ Johnson on Q4 2018 Results - Earnings Call Transcript

HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) Q4 2018 Results Earnings Conference Call March 7, 2019 4:30 PM ET Company Participants Monique Kosse - Investor Relations TJ Johnson - Chief Executive Officer John Lubniewski - President, Chief Operating Officer Shaun McMeans - Chief Financial Officer Conference Call Participants Alex Nowak - Craig-Hallum David Delahunt - SVB Leerink Yi Chen - H.C. Wainwright Operator Greetings, and welcome to the HTG Molecular Diagnostics Fourth Quarter and Full Year...

121
Seeking AlphaMar 12

HTG Molecular Diagnostics (HTGM) Presents At Cowen And Company 39th Annual Health Care Conference - Slideshow

The following slide deck was published by HTG Molecular Diagnostics, Inc. in conjunction with this event. 1 26 Click to enlarge Notes:...

7
Associated PressMar 7

HTG Molecular Diagnostics Reports Full Year 2018 Results

This content is a press release from our partner Globe Newswire. The AP newsroom and editorial departments were not involved in its creation. This content is a press release from our partner Globe Newswire. The AP newsroom and editorial departments were not involved in its creation. TUCSON, Ariz., March 07, 2019 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq:HTGM) (HTG), a life science company whose mission is to advance precision medicine, today reported its financial results for the year en...

1

Earnings

-$0.60
-$0.42
-$0.25
-$0.07
Q2 2017
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Estimated
-$0.18 per share
Actual
-$0.07 per share
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.